Markus Luber
Impact in
- Rheumatology top 10%
- Spondyloarthritis Studies and Treatments
- Rheumatoid Arthritis Research and Therapies
-
- Psoriasis: Treatment and Pathogenesis
- IL-33, ST2, and ILC Pathways
Papers in
-
- IL-33, ST2, and ILC Pathways 4
- Psoriasis: Treatment and Pathogenesis 2
-
- Systemic Sclerosis and Related Diseases 4
- Co-authors
- Georg Schett (7 shared papers)Andreas Ramming (6 shared papers)Jörg H. W. Distler (6 shared papers)Oliver Distler (2 shared papers)Clara Dees (2 shared papers)Christina Bergmann (2 shared papers)Rudolf Jaenisch (1 shared paper)Akihiko Yoshimura (1 shared paper)
- Journals
- Annals of the Rheumatic Diseases (4 papers)Physical review. B, Condensed matter (1 paper)The Journal of Immunology (1 paper)European Journal of Pharmaceutics and Biopharmaceutics (1 paper)Journal of Clinical Investigation (1 paper)
- Partner nations
- GermanySwitzerlandUnited States
In The Last Decade
Markus Luber
9 papers receiving 314 citations
Peers
Comparison fields: 5 of 74
- Rheumatology 83
- Immunology 102
- Nuclear Energy and Engineering 2
- Hematology 37
- Dermatology 22
Countries citing papers authored by Markus Luber
This map shows the geographic impact of Markus Luber's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Markus Luber with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Markus Luber more than expected).
Fields of papers citing papers by Markus Luber
This network shows the impact of papers produced by Markus Luber. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Markus Luber. The network helps show where Markus Luber may publish in the future.
Co-authors
The 25 scholars most cited alongside Markus Luber, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 110 | |
| 2 | 2018 | 75 | |
| 3 | 2019 | 43 | |
| 4 | 2021 | 37 | |
| 5 | 2010 | 35 | |
| 6 | 1995 | 11 | |
| 7 | 2021 | 6 | |
| 8 | 2021 | 1 | |
| 9 | 2020 | 1 | |
| 10 | 2020 | 0 | |
| 11 | 2025 | 0 | |
| 12 | 2018 | 0 |
About Markus Luber
Markus Luber is a scholar working on Immunology, Pathology and Forensic Medicine, Molecular Biology, Surgery and Epidemiology, having authored 12 papers that have together received 319 indexed citations. Recurring topics across this work include Systemic Sclerosis and Related Diseases (4 papers), IL-33, ST2, and ILC Pathways (4 papers), Psoriasis: Treatment and Pathogenesis (2 papers), Eosinophilic Esophagitis (2 papers), ZnO doping and properties (1 paper), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (1 paper), Protein purification and stability (1 paper) and Viral Infectious Diseases and Gene Expression in Insects (1 paper). The work is most often cited by research in Rheumatology (83 citations), Immunology (102 citations), Nuclear Energy and Engineering (2 citations), Hematology (37 citations) and Dermatology (22 citations). Markus Luber has collaborated with scholars based in Germany, Switzerland and United States. Frequent co-authors include Georg Schett, Andreas Ramming, Jörg H. W. Distler, Oliver Distler, Clara Dees, Christina Bergmann, Rudolf Jaenisch, Akihiko Yoshimura, Emmanuel Karouzakis and Kolja Gelse. Their work appears in journals such as Annals of the Rheumatic Diseases, Physical review. B, Condensed matter, The Journal of Immunology, European Journal of Pharmaceutics and Biopharmaceutics and Journal of Clinical Investigation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.